{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:21:11Z","timestamp":1768875671536,"version":"3.49.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.medcli.2013.04.027","type":"journal-article","created":{"date-parts":[[2013,6,12]],"date-time":"2013-06-12T11:22:07Z","timestamp":1371036127000},"page":"163-170","source":"Crossref","is-referenced-by-count":4,"title":["Tratamiento diur\u00e9tico en la insuficiencia cardiaca"],"prefix":"10.1016","volume":"142","author":[{"given":"Joan Carles","family":"Trull\u00e0s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Lu\u00eds","family":"Morales-Rull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesc","family":"Formiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2013.04.027_bib0005","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1161\/CIRCULATIONAHA.109.192065","volume":"119","author":"Hunt","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.medcli.2013.04.027_bib0010","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.medcli.2013.04.027_bib0015","series-title":"Farmacolog\u00eda humana","first-page":"931","article-title":"F\u00e1rmacos diur\u00e9ticos","author":"Fl\u00f3rez","year":"2008"},{"key":"10.1016\/j.medcli.2013.04.027_bib0020","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","article-title":"Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"149","author":"Adams","year":"2005","journal-title":"Am Heart J"},{"issue":"Suppl B","key":"10.1016\/j.medcli.2013.04.027_bib0025","doi-asserted-by":"crossref","first-page":"B13","DOI":"10.1093\/eurheartj\/sui008","article-title":"Reassessing treatment of acute heart failure syndromes: The ADHERE Registry","volume":"7","author":"Gheorghiade","year":"2005","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.medcli.2013.04.027_bib0030","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.cardfail.2007.03.011","article-title":"High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: A report from the ADHERE database","volume":"13","author":"Heywood","year":"2007","journal-title":"J Card Fail"},{"key":"10.1016\/j.medcli.2013.04.027_bib0035","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.amjcard.2005.12.072","article-title":"Relation of loop diuretic dose to mortality in advanced heart failure","volume":"97","author":"Eshaghian","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.medcli.2013.04.027_bib0040","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2013.04.027_bib0045","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra0907219","article-title":"Use of diuretics in patients with hypertension","volume":"361","author":"Ernst","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2013.04.027_bib0050","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.amjmed.2011.05.009","article-title":"Half a century of hydrochlorothiazide: Facts, fads, fiction, and follies","volume":"124","author":"Messerli","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.medcli.2013.04.027_bib0055","unstructured":"Consejo General de Colegios Oficiales de Farmac\u00e9uticos. BOT Plus web. Versi\u00f3n 5.0.0. Febrero 2011. Disponible en: https:\/\/botplusweb.portalfarma.com"},{"key":"10.1016\/j.medcli.2013.04.027_bib0060","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2010.06.034","article-title":"Combination of loop diuretics with thiazide-type diuretics in heart failure","volume":"56","author":"Jentzer","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.medcli.2013.04.027_bib0065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0002-8703(75)90041-1","article-title":"The supra-additive natriuretic effect addition of bendroflumethiazide and bumetanide in congestive heart failure. Permutation trial tests in patients in long-term treatment with bumetanide","volume":"89","author":"Sigurd","year":"1975","journal-title":"Am Heart J"},{"key":"10.1016\/j.medcli.2013.04.027_bib0070","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1093\/oxfordjournals.eurheartj.a014805","article-title":"Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure","volume":"17","author":"Dormans","year":"1996","journal-title":"Eur Heart J"},{"key":"10.1016\/j.medcli.2013.04.027_bib0075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0140-6736(90)90148-X","article-title":"Metolazone in treatment of severe refractory congestive cardiac failure","volume":"335","author":"Kiyingi","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2013.04.027_bib0080","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/hrt.71.2.146","article-title":"Combination diuretic treatment in severe heart failure: A randomised controlled trial","volume":"71","author":"Channer","year":"1994","journal-title":"Br Heart J"},{"key":"10.1016\/j.medcli.2013.04.027_bib0085","unstructured":"ClinicalTrials.gov. Safety and efficacy of the combination of loop with thiazide-type diuretics in patients with decompensated heart failure (CLOROTIC). Identifier: NCT01647932. [consultado 5 Mar 2013]. Disponible en: www.clinicaltrials.gov"},{"key":"10.1016\/j.medcli.2013.04.027_bib0090","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2147\/VHRM.S13779","article-title":"Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure","volume":"7","author":"Nappi","year":"2011","journal-title":"Vasc Health Risk Manag"},{"issue":"5 Suppl","key":"10.1016\/j.medcli.2013.04.027_bib0095","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1067\/mhj.2002.129969","article-title":"Aldosterone: Cardiovascular assault","volume":"144","author":"Struthers","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.medcli.2013.04.027_bib0100","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0002-9149(96)00465-1","article-title":"Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES])","volume":"78","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.medcli.2013.04.027_bib0105","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2013.04.027_bib0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2013.04.027_bib0115","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/CIRCHEARTFAILURE.108.821199","article-title":"Sodium retention in heart failure and cirrhosis: Potential role of natriuretic doses of mineralocorticoid antagonist?","volume":"2","author":"Bansal","year":"2009","journal-title":"Circ Heart Fail"},{"issue":"5 Pt 1","key":"10.1016\/j.medcli.2013.04.027_bib0120","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/0016-5085(83)90198-1","article-title":"Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system","volume":"84","author":"P\u00e9rez-Ayuso","year":"1983","journal-title":"Gastroenterology"},{"key":"10.1016\/j.medcli.2013.04.027_bib0125","doi-asserted-by":"crossref","first-page":"21A","DOI":"10.1016\/0002-9149(93)90241-4","article-title":"Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor","volume":"71","author":"Van Vliet","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.medcli.2013.04.027_bib0130","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1159\/000168356","article-title":"Aldosterone in congestive heart failure: Analysis of determinants and role in sodium retention","volume":"11","author":"Hensen","year":"1991","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.medcli.2013.04.027_bib0135","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJM199808063390607","article-title":"Diuretic therapy","volume":"339","author":"Brater","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2013.04.027_bib0140","first-page":"883","article-title":"Treatment of refractory congestive heart failure and normokalemic hypochloremic alkalosis with acetazolamide and spironolactone","volume":"123","author":"Khan","year":"1980","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.medcli.2013.04.027_bib0145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/ndt\/14.suppl_4.39","article-title":"Diuretic therapy and diuretic resistance in cardiac failure","volume":"14","author":"Kr\u00e4mer","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.medcli.2013.04.027_bib0150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1067\/mhj.2002.123144","article-title":"Diuretic resistance predicts mortality in patients with advanced heart failure","volume":"144","author":"Neuberg","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.medcli.2013.04.027_bib0155","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/archinte.162.3.265","article-title":"Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: The Rotterdam Study","volume":"162","author":"Feenstra","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.medcli.2013.04.027_bib0160","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ki.1989.246","article-title":"Mechanism of impaired natriuretic response to furosemide during prolonged therapy","volume":"36","author":"Loon","year":"1989","journal-title":"Kidney Int"},{"issue":"6 Pt 2","key":"10.1016\/j.medcli.2013.04.027_bib0165","first-page":"F1256","article-title":"Adaptation of distal tubule and collecting duct to increased sodium delivery. I. Ultrastructure","volume":"255","author":"Kaissling","year":"1988","journal-title":"Am J Physiol"},{"issue":"3 Pt 2","key":"10.1016\/j.medcli.2013.04.027_bib0170","first-page":"F374","article-title":"Structural adaptation of the distal convoluted tubule to prolonged furosemide treatment","volume":"248","author":"Kaissling","year":"1985","journal-title":"Am J Physiol"},{"key":"10.1016\/j.medcli.2013.04.027_bib0175","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/pgmj.53.617.117","article-title":"The urinary sodium: Potassium ratio and response to diuretics in resistant oedema","volume":"53","author":"Alexander","year":"1977","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.medcli.2013.04.027_bib0180","series-title":"Manejo integral del paciente con insuficiencia cardiaca cr\u00f3nica","first-page":"38","article-title":"Diur\u00e9ticos. Control de s\u00edntomas congestivos","author":"Formiga P\u00e9rez","year":"2011"},{"key":"10.1016\/j.medcli.2013.04.027_bib0185","first-page":"2067","article-title":"Diuretic strategies in patients with acute heart failure","volume":"364","author":"Escobar","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2013.04.027_bib0190","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/eurjhf\/hfr120","article-title":"Dangerous diuretics or death defying drugs?","volume":"13","author":"Damman","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.medcli.2013.04.027_bib0195","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/eurjhf\/hfr121","article-title":"Impact of diuretic dosing on mortality in acute heart failure using a propensity-matched analysis","volume":"13","author":"Yilmaz","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.medcli.2013.04.027_bib0200","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1001\/jama.291.16.1963","article-title":"Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: A randomized controlled trial","volume":"291","author":"Gheorghiade","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.medcli.2013.04.027_bib0205","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1161\/01.CIR.0000070422.41439.04","article-title":"Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: Results from a double-blind randomized trial","volume":"107","author":"Gheorghiade","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.medcli.2013.04.027_bib0210","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized with worsening heart failure: The EVEREST Outcome Trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.medcli.2013.04.027_bib0215","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1161\/hc4501.099313","article-title":"Acute hemodynamic effects of conivaptan, a dual V1A and V2 vasopressin receptor antagonist, in patients with advanced heart failure","volume":"104","author":"Udelson","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.medcli.2013.04.027_bib0220","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.cardfail.2011.08.012","article-title":"Renal effects of conivaptan, furosemide, and the combination in patients with chronic heart failure","volume":"17","author":"Goldsmith","year":"2011","journal-title":"J Card Fail"},{"key":"10.1016\/j.medcli.2013.04.027_bib0225","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jacc.2006.07.073","article-title":"Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure","volume":"49","author":"Costanzo","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.medcli.2013.04.027_bib0230","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","article-title":"Ultrafiltration in decompensated heart failure with cardiorenal syndrome","volume":"367","author":"Bart","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2013.04.027_bib0235","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/MAJ.0b013e31820f10ad","article-title":"Short-term effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restriction in patients with compensated heart failure with New York Heart Association class iii (Class C) (SMAC-HF Study)","volume":"342","author":"Paterna","year":"2011","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.medcli.2013.04.027_bib0240","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.cardfail.2010.07.246","article-title":"Impact of dopamine infusion on renal function in hospitalized heart failure patients: Results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial","volume":"16","author":"Giamouzis","year":"2010","journal-title":"J Card Fail"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775313003114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775313003114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T03:37:20Z","timestamp":1563161840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775313003114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0025775313003114"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2013.04.027","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}